مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

405
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

121
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARISON OF PHOSPHATE LOWERING PROPERTIES OF CALCIUM ACETATE AND CALCIUM CARBONATE IN HEMODIALYSIS

Pages

  73-76

Abstract

 Hyperphosphatemia has an important role in the development of secondary hyperparathyroidism and bone disease in patients with end-stage renal disease (ESRD). The most effective method of phosphate elimination lies with phosphate binders, the agent that more commonly used, calcium carbonate, is not an idial binding agent. In this regard, CALCIUM ACETATE has been reported to have more or at least a similar phosphate binding efficacy and less pronounced hypercalcemic effect. However, this subject is still a matter of controversy. This study was designed to compare the efficiency of these salts. Preparation of CALCIUM ACETATE and comparison of the phosphate binding power and hypercalcemic effect of CALCIUM ACETATE with that of calcium carbonate in HEMODIALYSIS patients. Thirty stable ESRD patients undergoing regular HEMODIALYSIS for mean 4.23 years (SD 3.63) were studied. Half of the patients were started on CALCIUM ACETATE for a month. Then, after two weeks wash out period, they received calcium carbonate for a month. The others followed an inverse protocol. 24 patients completed the study. A significant decrease in plasma phosphate levels was only observed after treatment with CALCIUM ACETATE [6.65 mg/dL (SD 1.38 vs. 5.83 mg/dL (SD 1.55) p < 0.05]. CALCIUM ACETATE may be a better choice in handling of hyperphophatemia in ESRD patients and when CALCIUM ACETATE is used, control of hyperphophatemia can be better achieved with a lower risk of HYPERCALCEMIA.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    NAGHIBI, M., NAZEMIAN, F., RAJABI, O., & HAMI, M.. (2006). COMPARISON OF PHOSPHATE LOWERING PROPERTIES OF CALCIUM ACETATE AND CALCIUM CARBONATE IN HEMODIALYSIS. IRANIAN JOURNAL OF PHARMACOLOGY AND THERAPEUTICS (IJPT), 5(1), 73-76. SID. https://sid.ir/paper/297104/en

    Vancouver: Copy

    NAGHIBI M., NAZEMIAN F., RAJABI O., HAMI M.. COMPARISON OF PHOSPHATE LOWERING PROPERTIES OF CALCIUM ACETATE AND CALCIUM CARBONATE IN HEMODIALYSIS. IRANIAN JOURNAL OF PHARMACOLOGY AND THERAPEUTICS (IJPT)[Internet]. 2006;5(1):73-76. Available from: https://sid.ir/paper/297104/en

    IEEE: Copy

    M. NAGHIBI, F. NAZEMIAN, O. RAJABI, and M. HAMI, “COMPARISON OF PHOSPHATE LOWERING PROPERTIES OF CALCIUM ACETATE AND CALCIUM CARBONATE IN HEMODIALYSIS,” IRANIAN JOURNAL OF PHARMACOLOGY AND THERAPEUTICS (IJPT), vol. 5, no. 1, pp. 73–76, 2006, [Online]. Available: https://sid.ir/paper/297104/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button